Argeris N Karabelas's Net Worth

$150 Million

Estimate Recalculated Jul 19, 2024 03:36PM EST

Who is Argeris N Karabelas?

Argeris N Karabelas has an estimated net worth of $150 Million. This is based on reported shares across multiple companies, which include BIODELIVERY SCIENCES INTERNATIONAL INC, Bausch Health Companies Inc., REGENXBIO Inc., Vanda Pharmaceuticals Inc., INOTEK PHARMACEUTICALS CORP, HUMAN GENOME SCIENCES INC, ANADYS PHARMACEUTICALS INC, and NITROMED INC.

SEC CIK

Argeris N Karabelas's CIK is 0001191229

Past Insider Trading and Trends

2006 was Argeris N Karabelas's most active year for acquiring shares with 8 total transactions. Argeris N Karabelas's most active month to acquire stocks was the month of April. 2009 was Argeris N Karabelas's most active year for disposing of shares, totalling 36 transactions. Argeris N Karabelas's most active month to dispose stocks was the month of June. 2015 saw Argeris N Karabelas paying a total of $3,683,352.00 for 2,088,620 shares, this is the most they've acquired in one year. In 2006 Argeris N Karabelas cashed out on 13,997,534 shares for a total of $37,736,577.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BIODELIVERY SCIENCES INTERNATIONAL INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Form 4
-100.00%
-159.14K
$6.74
-$1,071,928.81
0
Jul 15 - Jul 16
Form 4
-7.78%
-13.42K
$6.13
-$82,214.79
159.14K
Jul 7 - Jul 8
Form 4
-30.72%
-76.51K
$6.20
-$474,506.41
172.56K
Jul 2 - Jul 6
Form 4
-24.91%
-82.64K
$6.72
-$555,677.70
249.07K
Jun 30 - Jul 1
Form 4
-67.64%
-693.30K
$6.86
-$4,757,413.02
331.71K
Jun 26 - Jun 29
Form 4
-4.79%
-51.52K
$6.50
-$334,921.01
1.03M
Jun 24 - Jun 25
Form 4
-3.97%
-44.46K
$6.37
-$283,190.70
1.08M
Jun 22 - Jun 23
Form 4
-8.98%
-110.61K
$6.54
-$723,515.11
1.12M
Jun 19
Form 4
-11.71%
-163.39K
$6.44
-$1,052,398.99
1.23M
Jun 17 - Jun 18
Form 4
-30.25%
-605.00K
$7.14
-$4,321,999.60
1.4M
Jun 15 - Jun 16
Form 4
—
0
—
—
0
Mar 12
Form 3
—
0
—
—
0
No matching records found

Bausch Health Companies Inc. (BHC) Snapshot price: $8.13

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+38.50%
34.39K
—
—
123.72K
Jun 24
Form 4
+9.36%
7.64K
—
—
89.33K
Apr 30
Form 4
+15.62%
11.04K
—
—
81.68K
May 1
Form 4
+17.72%
10.63K
$23.51
$249,981.83
70.65K
May 3
Form 4/A
+30.09%
13.88K
—
—
60.01K
May 3
Form 4
+30.97%
14.29K
—
—
60.42K
May 3
Form 4
+122.58%
25.41K
—
—
46.13K
May 5
Form 4
+23.91%
4K
$24.65
$98,600.00
20.73K
Aug 11
Form 4
∞
16.73K
—
—
16.73K
Jun 17
Form 3
—
0
—
—
0
No matching records found

REGENXBIO Inc. (RGNX) Snapshot price: $13.98

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$7.52
-$75,091.00
11.29K
Jul 1
Form 4
+73.74%
4.79K
—
—
11.29K
May 31
Form 4
+115.81%
3.49K
—
—
6.5K
Jun 2
Form 4
∞
3.01K
—
—
3.01K
Jun 3
Form 4
—
0
—
—
0
Jun 4
Form 4
—
0
—
—
0
May 29
Form 4
—
0
—
—
0
May 31
Form 4
—
0
—
—
0
May 25
Form 4
—
0
—
—
0
May 24
Form 4
—
0
—
—
0
Jun 1
Form 4/A
—
0
—
—
0
Sep 16
Form 4
—
0
—
—
0
Sep 16
Form 3
—
0
—
—
0
No matching records found

Vanda Pharmaceuticals Inc. (VNDA) Snapshot price: $3.74

Chairman the Board

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Jun 3
Form 4
-100.00%
-200.00K
$11.80
-$2,360,000.00
0
Mar 12
Form 4
-53.37%
-228.92K
$11.09
-$2,539,331.72
200K
Dec 14 - Dec 15
Form 4
-23.75%
-133.58K
$11.52
-$1,538,352.80
428.92K
Dec 8 - Dec 9
Form 4
-26.23%
-200.00K
$11.64
-$2,327,000.00
562.5K
Dec 4 - Dec 7
Form 4
-23.75%
-237.50K
$12.65
-$3,004,375.00
762.5K
Oct 13
Form 4
—
0
—
—
0
Aug 27
Form 4
—
0
—
—
0
May 8
Form 4
—
0
—
—
0
May 16
Form 4
-27.75%
-384.13K
$26.02
-$9,993,756.56
1M
Feb 23
Form 4
-4.98%
-72.60K
$26.82
-$1,947,328.02
1.38M
Feb 22
Form 4
-12.18%
-437.00K
$27.06
-$11,811,740.00
3.15M
Feb 20 - Feb 21
Form 4
-18.30%
-424.15K
$25.18
-$10,680,097.00
1.89M
Dec 12
Form 4
-12.34%
-326.32K
$26.40
-$8,614,980.00
2.32M
Dec 11
Form 4
-10.19%
-300.00K
$14.18
-$4,254,000.00
2.64M
Nov 27
Form 4
-9.25%
-300.00K
$14.12
-$4,236,000.00
2.94M
Nov 22
Form 4
-1.52%
-50.00K
$14.55
-$727,500.00
3.24M
Nov 21
Form 4/A
-4.60%
-320.00K
$14.77
-$4,612,000.00
6.64M
Nov 17 - Nov 20
Form 4
-3.19%
-320.00K
$14.77
-$4,612,000.00
9.72M
Nov 17 - Nov 20
Form 4
+233.89%
3.61M
—
—
5.16M
Apr 18
Form 3
—
0
—
—
0
No matching records found

INOTEK PHARMACEUTICALS CORP (RCKT) Snapshot price: $28.79

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 24
Form 4
+958.63%
2.06M
$6.00
—
2.28M
Feb 23
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found